116 related articles for article (PubMed ID: 4150944)
1. A possible interaction of quipazine with central dopamine structures.
Grabowska M; Antkiewicz L; Michaluk J
J Pharm Pharmacol; 1974 Jan; 26(1):74-6. PubMed ID: 4150944
[No Abstract] [Full Text] [Related]
2. Quipazine, a new type of antidepressant agent.
Rodríguez R; Pardo EG
Psychopharmacologia; 1971; 21(1):89-100. PubMed ID: 5567294
[No Abstract] [Full Text] [Related]
3. Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin.
Langlais PJ; Gabay S
J Neurosci Res; 1977; 3(2):135-41. PubMed ID: 563925
[TBL] [Abstract][Full Text] [Related]
4. On the role of the central serotoninergic system in the regulation of the secretion of thyrotropin and prolactin: thyrotropin-inhibiting and prolactin-releasing effects of 5-hydroxytryptamine and quipazine in the male rat.
Krulich L; Vijayan E; Coppings RJ; Giachetti A; McCann SM; Mayfield MA
Endocrinology; 1979 Jul; 105(1):276-83. PubMed ID: 446410
[No Abstract] [Full Text] [Related]
5. The influence of LSD on locomotor activity in reserpinized mice.
Grabowska M; Antikiewicz L; Michaluk J
Pol J Pharmacol Pharm; 1974; 26(5):499-504. PubMed ID: 4427810
[No Abstract] [Full Text] [Related]
6. Dopaminergic activity of quipazine.
Schechter MD; Concannon JT
Pharmacol Biochem Behav; 1982 Sep; 17(3):393-7. PubMed ID: 7146043
[TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazine.
Rokosz-Pelc A; Antkiewicz-Michaluk L; Vetulani J
J Pharm Pharmacol; 1980 Mar; 32(3):220-2. PubMed ID: 6103943
[No Abstract] [Full Text] [Related]
8. The influence of quipazine on the turnover rate of serotonin.
Grabowska M; Antkiewicz L; Michaluk J
Biochem Pharmacol; 1974 Nov; 23(22):3211-2. PubMed ID: 4441411
[No Abstract] [Full Text] [Related]
9. Participation of dopamine- and serotonin- receptors in the disaggregation of brain polysomes by L-dopa and L-5-HTP.
Weiss BF; Liebschutz JL; Wurtman RJ; Munro HN
J Neurochem; 1975 Jun; 24(6):1191-5. PubMed ID: 1079238
[No Abstract] [Full Text] [Related]
10. Evidence for the role of noradrenaline in some effects of quipazine.
Francès H; Lecrubier Y; Puech AJ; Simon P
Psychopharmacology (Berl); 1980; 67(3):307-10. PubMed ID: 6770410
[TBL] [Abstract][Full Text] [Related]
11. Dose-response shifts in the behavioural effects of dopamine agonists and antagonists following chronic morphine treatment.
Overstreet DH; Smee ML; Woolston ME
Proc West Pharmacol Soc; 1976; 19():248-53. PubMed ID: 1033554
[No Abstract] [Full Text] [Related]
12. [Pharmacological study of a possible dopamine metabolite, tetrahydropapaveroline].
Simon P; Goujet MA; Chermat R; Boissier JR
Therapie; 1971; 26(6):1175-92. PubMed ID: 5146531
[No Abstract] [Full Text] [Related]
13. The effects of serotonin injections into the locus coeruleus on ponto geniculo occipital (PGO) waves and cortical EEG pattern in cats.
Kostowski W; Gumulka W; Jerlicz M
Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):127-37. PubMed ID: 1208222
[TBL] [Abstract][Full Text] [Related]
14. The effects of cyproheptadine, methysergide, BC 105 and reserpine on brain 5-hydroxytryptamine and brain growth.
Hole K
Eur J Pharmacol; 1972 Aug; 19(2):156-9. PubMed ID: 5071787
[No Abstract] [Full Text] [Related]
15. Similarities between the pharmacological actions of quipazine and serotonin.
Hong E; Sancilio LF; Vargas R; Pardo EG
Eur J Pharmacol; 1969; 6(3):274-80. PubMed ID: 5816391
[No Abstract] [Full Text] [Related]
16. [Antiserotonergic effect of antidepressives in quipazine-induced headshake behavior in the rat].
Fischer W; Müller M
Pharmazie; 1984 Nov; 39(11):776-7. PubMed ID: 6531385
[No Abstract] [Full Text] [Related]
17. Head twitches induced by LSD and quipazine: similarities and differences.
Vetulani J; Bednarczyk B; Reichenberg K; Rokosz A
Neuropharmacology; 1980 Feb; 19(2):155-8. PubMed ID: 6244515
[No Abstract] [Full Text] [Related]
18. Serotonin neuroleptics change patterns of preovulatory secretion of luteinizing hormone in rats.
Walker RF
Life Sci; 1980 Sep; 27(12):1063-8. PubMed ID: 7191463
[No Abstract] [Full Text] [Related]
19. Effects of cyproheptadine on prolactin synthesis and release by normal and suppressed pituitary glands and by dispersed pituitary tumor cells.
Lamberts SW; MacLeod RM
Endocrinology; 1978 Nov; 103(5):1710-7. PubMed ID: 748012
[No Abstract] [Full Text] [Related]
20. Short- and long-term regulation of tyrosine hydroxylase.
Costa E; Guidotti A; Zivkovic B
Adv Biochem Psychopharmacol; 1974; 12(0):161-75. PubMed ID: 4154019
[No Abstract] [Full Text] [Related]
[Next] [New Search]
